Save money and time, get standardized analysis
Analyses from the same vendor for 14 different EU countries
We will help you navigate through the challenges of reimbursement and funding for medical devices and in-vitro diagnostics in Europe
MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry
MTRC is a unique provider of Pan-European reimbursement services and products for Med Tech and IVD industry
Scope
Coding, payment mechanism tariffs
Countries
14 EU
Pricing
On request
Availability
On-demand
Scope
Pathway to create or improve reimbursement situation
Countries
14 EU
Pricing
On request
Availability
On-demand
Scope
Stakeholders, money flow, payment model, HTA landscape, funding, reimbursement pathway
Countries
14 EU
Pricing
1500€
Availability
Off-the-shelf
Scope
One day, on-site training on key aspects of market access
Countries
14 EU
Pricing
5000€
Availability
On-demand
Scope
Coding, payment mechanism tariffs for a specific procedure
Countries
11 EU
Pricing
On request
Availability
Off-the-shelf
Why us?
Pharma approach is put aside
Work with a company truly specialized in medical devices and diagnostics
Getting results instantly (reports) or within 4-8 weeks (services)
Make business decisions quickly
12 out of top-30 companies choose MTRC for reimbursement support
Work with a provider who understand industry’s needs
More than 110 projects accomplished during the last year
Work with a provider who has experience in your field
Team of 15 specialists in 6 countries
Work with a provider with a Pan-European capacity
More than 200 internal instructions and protocols
Be sure about quality of the results
To stay up-to-date, we daily monitor developments of reimbursement systems in Europe
Subscribe to our newsletter to get updates every 2nd week
01 Jun 2018
European Med Tech and IVD Reimbursement Consulting Ltd. released a report, which identifies and provides an overview of the innovative payment schemes for medical devices and in-vitro diagnostic tests in European countries. The report was supported by the grant from the Med Tech Europe. Access the full version of the report at our web-site.
18
Sep 2018
On July 27th, 2018, the European network for HTA has published a rapid assessment of the continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin.
17
Sep 2018
On 20th of July, 2018, the Austrian HTA body, the Ludwig-Boltzmann Institute (LBI) has published an update of the HTA of high-intensity focused ultrasound (HIFU) for the treatment of prostate cancer. The report did not find the evidence of benefits of the treatment vs comparative treatments. The inclusion of the method hospital benefit catalogue was currently not recommended.
14
Sep 2018
In July of 2018, the Federal Joint Committee (G-BA) has initiated the discussion regarding the establishment of the minimum quantity requirements for the surgical treatment of breast cancer and bronchial carcinoma. As the quality of surgery is directly dependent on the quantity, the number of operations performed at hospital and on the designated surgeon, the objective is to understand the importance of the experience and routine practice of the operations to reach the successful treatment outcomes and to determine a minimum number of operations, which should be performed in hospitals to gain enough experience.
13
Sep 2018
In July of 2018, the Dental and Pharmaceutical Benefits Agency (Tandvårds-Läkemedelförmånsverket, TLV) has updated the product group codes for consumables for better understanding the range of the products. Editorial changes to the codes' descriptions were implemented. Seven new groups for stomach products, plates and bags of different types, which are especially intended for children have been included in the classification.
Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 14 European countries
| Analysis | |
Reimbursement
|
National fundingWillingness to pay for technology, based on:
|
| Strategy |
Reimbursement strategyPathway to get reimbursement:
|
Check our specific propositions for: Med Tech industry, IVD industry, Investors
Our services cover 14 European countries, including Austria, Belgium, Denmark, England, Finland, France, Germany, Italy, the Netherlands, Norway, Russia, Spain, Sweden and Switzerland
We provide services for major types of medical technologies
|
Implantable devices |
Interventional procedures |
Non-interventional procedures |
In-vitro diagnostic tests |
Medical aids |
|
Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring and insulin injection, use of fusidial markers, radiotherapy, endoscopy and more
|
Confidence in results
We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:
- Standard Operating Procedures and Work Instructions
- Access to official coding and DRG manuals, tariff lists and grouping software
- A team comprised of experienced Clinical Coders with a medical background
- Quick access to health authorities to address uncertainties
- Ongoing research program to get insights from payer and provider interviews
- All reports are reviewed by the CEO before release
Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries
Released reports:
|
Ongoing reports:
|